By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Novartis AG 

Lichtstrasse 35

Basel    CH-4056  Switzerland
Phone: 41-0-61-3241111 Fax: 41-0-61-3248001


SEARCH JOBS

Novartis is located in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2015, the Group achieved net sales of USD 49.4 billion, while R&D throughout the Group amounted to approximately USD 8.9 billion (USD 8.7 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are available in more than 180 countries around the world.

For more information, visit
www.novartis.com and follow us on www.twitter.com/Novartis

YEAR FOUNDED:

1996

LEADERSHIP:

CEO: Joseph Jimenez

CMO: Vasant (Vas) Narasimhan

CFO: Harry Kirsch

JOBS:

Please click here for Novartis job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

PRODUCTS:

All Products

FOLLOW NOVARTIS:








Key Statistics


Email:
Ownership: Subsidiary

Web Site: Novartis AG
Employees:
Symbol: NVS
 



Industry
Services






Company News
Novartis AG (NVS) Receives Positive CHMP Opinion For Rydapt (Midostaurin) For Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) And Three Types Of Advanced Systemic Mastocytosis (SM) 7/21/2017 8:41:01 AM
FDA Accepts Biologics License Application For AMG 334 (Erenumab), An Important Regulatory Milestone For Novartis AG (NVS) 7/21/2017 6:55:45 AM
Backed by Novartis AG (NVS) and Sanofi (SNY), NeuroVia Banks $14 Million to Take Lead Drug Into Clinic 7/20/2017 7:07:59 AM
Novartis AG (NVS) Boss Updates Q2 Financials and Reaffirms M&A Strategy 7/19/2017 6:08:37 AM
Novartis AG (NVS)'s Long-Suffering Alcon (ACL) Sees Sales Growth in Q2, Opening Door to Spin-Off IPO 7/18/2017 6:56:54 AM
Novartis AG (NVS) Confirms 5 Year Data For First And Only Fully-Human IL-17A Inhibitor Cosentyx Reinforcing Sustained Efficacy And Safety Profile In Psoriasis 7/17/2017 6:35:51 AM
Novartis AG (NVS) Stocking Up on "Big-3" Arthritis Blockbusters to Get an Edge on Rivals 7/14/2017 6:44:46 AM
The Alliance For Regenerative Medicine Issues Statement On U.S. FDA Oncologic Drugs Advisory Committee Meeting Regarding FDA CAR-T Product Biologics License Application 7/13/2017 10:27:30 AM
FDA Panel Unanimously Endorses Novartis AG (NVS)'s CAR-T Leukemia Drug 7/13/2017 5:40:19 AM
Novartis AG (NVS) Avoided Deaths In CAR-T Trials But Long-Term Safety Is Key, Says The FDA 7/11/2017 5:53:18 AM
12345678910...
//-->